Takeda nearing preliminary agreement to buy Shire after sweetening offer

Takeda nearing preliminary agreement to buy Shire after sweetening offer

A blister pack containing Mezavant XL anti-inflammatory tablets, produced by Shire Plc, sits on a pharmacy counter in this arranged photograph in London, U.K., on Thursday, Dec. 29, 2016. Photographer: Chris Ratcliffe/Bloomberg

Takeda Pharmaceutical Co. is nearing a preliminary agreement to acquire Shire Plc after the Japanese drugmaker sweetened its roughly $60 billion bid for the biotechnology company, according to people with knowledge of the matter.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter